Review
Human DNA topoisomerase II: biochemistry and role in chemotherapy resistance (review)
Affiliations
- PMID: 8712715
Item in Clipboard
Review
Human DNA topoisomerase II: biochemistry and role in chemotherapy resistance (review)
Anticancer Res.
1996 Jul-Aug.
Abstract
Recently, it has been discovered that DNA topoisomerases are the target of many anti-cancer drugs which were already widely used in the clinic. Using the latest molecular biological techniques much has been learned about the function of DNA topoisomerases in normal cells and in cancer cells, and about how anticancer drugs inhibit these enzymes. In this review we present an overview of the function of human type II DNA topoisomerases, how they are inhibited by certain drugs and on how cancer cells may become resistant to these drugs.
Similar articles
-
Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines.Cancer Res. 1998 Apr 1;58(7):1460-8. Cancer Res. 1998. PMID: 9537249
-
Human deoxyribonucleic acid topoisomerases: molecular targets of anticancer drugs.Ann Clin Lab Sci. 1997 Nov-Dec;27(6):402-12. Ann Clin Lab Sci. 1997. PMID: 9433537
-
DNA topoisomerase II as a potential factor in drug resistance of human malignancies.NCI Monogr. 1987;(4):105-9. NCI Monogr. 1987. PMID: 3041236
-
From DNA damage to G2 arrest: the many roles of topoisomerase II.Prog Cell Cycle Res. 2003;5:295-300. Prog Cell Cycle Res. 2003. PMID: 14593724 Review.
-
Topoisomerase II as a target for anticancer chemotherapy.Acta Biochim Pol. 1995;42(4):381-93. Acta Biochim Pol. 1995. PMID: 8852329 Review.
Cited by
-
Personalized medicine in breast cancer: pharmacogenomics approaches.Pharmgenomics Pers Med. 2019 May 27;12:59-73. doi: 10.2147/PGPM.S167886. eCollection 2019. Pharmgenomics Pers Med. 2019. PMID: 31213877 Free PMC article. Review.
-
High-Copy Overexpression Screening Reveals PDR5 as the Main Doxorubicin Resistance Gene in Yeast.PLoS One. 2015 Dec 21;10(12):e0145108. doi: 10.1371/journal.pone.0145108. eCollection 2015. PLoS One. 2015. PMID: 26690737 Free PMC article.
-
Total synthesis reveals atypical atropisomerism in a small-molecule natural product, tryptorubin A.Science. 2020 Jan 24;367(6476):458-463. doi: 10.1126/science.aay9981. Epub 2020 Jan 2. Science. 2020. PMID: 31896661 Free PMC article.
-
Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification.Br J Cancer. 2012 Feb 28;106(5):916-22. doi: 10.1038/bjc.2012.32. Epub 2012 Feb 14. Br J Cancer. 2012. PMID: 22333602 Free PMC article.
-
Quantitative Proteomic Profiling of Tachyplesin I Targets in U251 Gliomaspheres.Mar Drugs. 2017 Jan 18;15(1):20. doi: 10.3390/md15010020. Mar Drugs. 2017. PMID: 28106765 Free PMC article.